Search Within
Document Type
373-57-9
Applied Filters:
Keyword:'373-57-9'
Showing 1-30 of 38 results for "373-57-9" within Technical Documents
Product Information Sheet - B1252
solution
Product N umber B 1252
Storage Temperature 2-8 °C
Product Description
CAS Number: 373-57-9
The principle use of Boron Trifluoride in methanolic
solutions is to derivatize fatty acids.1,2
Data Sheet - C7512
using ion transfer
across the interface between two immiscible
liquids. Anal. Chem., 66, 52-57 (1994).
9. Ralston, J.S., et al, Use of procainamide gels in the
purification of human and horse serum
Butyrylcholinesterase (B7061)
gorge conformations analysed by
combinatorial mutations and enantiomeric
phosphonates. Biochem. J., 373, 33-40 (2003).
2. Savini, L., et al., Specific targeting of
acetylcholinesterase and butyrylcholinesterase
Data Sheet - H2289
J. Biol. Chem., 269, 20780-
20784 (1994).
9. Mehlen, P., et al., J. Biol. Chem., 271, 16510-
16514 (1996).
10. Garrido, C., et al., Cancer Res., 57, 2661-2667
(1997).
11. Bruey, J-M., et
Data Sheet - F5421
conjugated to KLH with glutaraldehyde as immunogen.
The peptide corresponds to amino acid residues 360-373
of the extracellular region of human FGFR-1 with a C-
terminally added lysine.
Anti-FGFR-1 may
Data Sheet - P1498
J. Biol. Chem., 269, 20780-
20784 (1994).
9. Mehlen, P., et al., J. Biol. Chem., 271, 16510-
16514 (1996).
10. Garrido, C., et al., Cancer Res., 57, 2661-2667
(1997).
11. Bruey, J-M., et al
XP725 Antibody Number-Lot Number 071M4826
25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80
1.3 9 10 11 12 33 34 35 36 57 58 59 60
TB429 pET-51b(+) Vector Map
1417 2481 4495
Bpu10I 1 2060
BpuEI 6 21 1904 3045 3343 3584
3960
BsaAI 2 2706 4976
BsaBI 3 363 373 2151
BsaHI 7 193 413 434 548 1047
1730 4024
BsaI 1 4498
BsaWI 8 2 201 1409 1912 2143
MILLIPORE IHC SELECT RESEARCH® PREDILUTED RABBIT ANTI-TYROSINE HYDROXYLASE AFFINITY PURIFIED POLYCLONAL ANTIBODY
afferents in ferret
primary auditory cortex (AI) during postnatal development. Journal of Anatomy 186 : 373-
382.
Albers, K., et al. (1994). Overexpression of nerve growth factor in epidermis of transgenic
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
402 11 336 8 536 14 802 22 679 17 57 1 474 12 519 13 1369 33 189 4 1167 30
IPI00021841 Apolipoprotein A-I precursor 430 10 674 9 378 10 848 13 538 11 899 13 369
TB416VM pET-48b(+) Vector Map
1 4319
NsiI 2 4512 4778
NspI 4 1071 2805 3097 3464
NspV 1 187
PacI 1 141
PciI 1 3460
Pfl MI 4 179 373 1178 4925
PfoI 2 1163 3102
PpiI 2 4175 5329
PpuMI 2 310 2466
PshAI 1 262
PsiI 1 5235
PspOMI 1 1803
TB417VM pET-49b(+) Vector Map
2 4833 5099
NspI 5 849 1392 3126 3418 3785
NspV 2 187 688
PacI 1 141
PciI 2 845 3781
Pfl MI 4 179 373 1499 5246
PfoI 2 1484 3423
PpiI 2 4496 5650
PpuMI 2 310 2787
PshAI 1 262
PsiI 1 5556
PspOMI 1 2124
Product Information Sheet - 11373099910
weight marker II,
digoxigenin-labeled (1.5–6.9 kb)
Cat. No. 11 526 529 910 4 �g (200 �l) Cat. No. 11 373 099 910 2 �g (200 �l)
Cat. No. 11 526 537 910 2 �g (200 �l) y Version 11
Content
Product Information Sheet - 11526529910
weight marker II,
digoxigenin-labeled (1.5–6.9 kb)
Cat. No. 11 526 529 910 4 �g (200 �l) Cat. No. 11 373 099 910 2 �g (200 �l)
Cat. No. 11 526 537 910 2 �g (200 �l) y Version 12
Content
Product Information Sheet - 11526537910
weight marker II,
digoxigenin-labeled (1.5–6.9 kb)
Cat. No. 11 526 529 910 4 �g (200 �l) Cat. No. 11 373 099 910 2 �g (200 �l)
Cat. No. 11 526 537 910 2 �g (200 �l) y Version 11
Content
Product Information Sheet-fpcrn-ro
Biotin-16-dUTP 50 nmol, 50 µl, 1 mM 11 093 070 910
Fluorescein-12-dUTP 25 nmol, 25 µl, 1 mM 11 373 242 910
1 2 3
1 2 3
https://www.sigmaaldrich.com
Celltransmissions Newsletter
muscle,
prostate
cAMP/cGMP Unknown
Dipyridamole (D 9766)
Zaprinast (Z 0878)
0.82-1.8 [57]
5-28 [57]
Inhibitors of Cyclic Nucleotide Phosphodiesterases...(continued)
http://www.sigma-aldrich.com
An Update on Ligands for Prostanoid Receptors
Essent. Fatty Acids, 49, 939-943 (1993).
50. Tsai, B.S., et al., J. Pharmacol. Exp. Ther., 275, 368-373 (1995).
51. Yokotani, K., et al., Eur. J. Pharmacol., 459, 187-193 (2003).
52. Kiriyama, M., et al.
Protein Tyrosine Phosphatases- Potential Roles in Disease
al., Immunol. Lett., 57, 101-103 (1997).
55. Hundt, M. and Schmidt, R.E., Eur. J. Immunol., 27, 3532-3535 (1997).
56. Tangye, S.G., et al., J. Immunol., 161, 3249-3255 (1998).
57. Tangye, S.G., et al.
Chromatographic Purification of Plasmid DNA
amount (µg)
Total pDNA
(µg)
ccc-form (%)
of total pDNA
load 2,588 3,318 78
break through 373 609 N/A
eluate pool 1,840 2,117 87
pDNA-form Recovery (%) Elution yield (%)
total pDNA 82
Chrombook 2015 - The world of chromatography in your hands
479
LiChroCART® 370, 373
LiChrolut® 56, 58
LiChrolut® EN 60
LiChrolut® extraction unit and drying attachment 64
LiChrolut® RP-18 58, 60
LiChrolut® selection guide 57
LiChrolut® sorbents 43
Acta Interactive Archive Vol 51
:1)
65 oC, 2 h
78%
69%
57%
31 other examples, 32–82%
NH
NO
Me
N
NO
Me
N•
NO
Me
84 mg (0.2 mmol)
2.1 g (5 mmol)
10.1 g (24
Inhibitor Sourcebook 3rd Edition
..................................................... 57
ML-9, Hydrochloride.................................................................... 57
MMP Inhibitor I ......................................
Hallmarks of Cancer - Solutions for life science research
www.emdmillipore.com/US/en/product/%2CMM_NF-FCMAB426PE?cid=BI-XX-BRC-C-EPDF-ANTI-B024-1601
57
Tumor-promoting Inflammation 9
EMD Millipore offers effective solutions for research on topics
related to Inflammation
Benzonase endonuclease - The Smart Solution for DNA Removal
al. (2008) DNA digestion to desoxyribonucleoside:
A simplified one-step procedure. Anal. Biochem. 373, 383.
Tang, R., et al. (2008) Development of a PIV-vectored RSV vaccine:
Preclinical evaluation
inNovations Newsletter #13
) J. Biol.
Chem. 249, 2220–2227.
20. Slutzky, G. M. and Ji, T. H. (1974)
Biochim. Biophys. Acta 373, 337–346.
21. Deutsch, D. G. (1976) Anal. Biochem.
71, 300-303.
22. Franklin, S. G. and Zweidler
XP725 Antibody List Lot 089K4791
PLA2G5 M NP_000920.1 y n/d n/d
568 Phospholipase C g1 (PLC g1) P8104 5335 PLCG1 P NP_002651.2 y y n/d
373 hPlk1 P5998 5347 PLK1 M NP_005021.2 y y y
374 hPlk1 P6123 5347 PLK1 M NP_005021.2 y y y
443 MCH M8440
XP725 Antibody List Lot 129K4830
PLA2G5 M NP_000920.1 y n/d n/d
568 Phospholipase C g1 (PLC g1) P8104 5335 PLCG1 P NP_002651.2 y y n/d
373 hPlk1 P5998 5347 PLK1 M NP_005021.2 y y y
374 hPlk1 P6123 5347 PLK1 M NP_005021.2 y y y
443 MCH M8440
XP725 Antibody List Lot 129K4831
PLA2G5 M NP_000920.1 y n/d n/d
568 Phospholipase C g1 (PLC g1) P8104 5335 PLCG1 P NP_002651.2 y y n/d
373 hPlk1 P5998 5347 PLK1 M NP_005021.2 y y y
374 hPlk1 P6123 5347 PLK1 M NP_005021.2 y y y
443 MCH M8440
3D BIOPRINTING: Printing a Brighter Future
. 2015, 25, 7406–7417.
(43) Morris, E. R.; Nishinari, K.; Rinaudo, M. Food Hydrocoll. 2012, 28, 373–
411.
(44) Shi, R.; Sun, T. L.; Luo, F.; Nakajima, T.; Kurokawa, T.; Bin, Y. Z.;
Rubinstein, M.
Page 1 of 2